Equities.com interviews Manit Patel, Chief Scientist of Verde Science at the AEGIS Capital 2014 Healthcare & Technology Conference
September 22, 2014 – Manit Patel, Verde’s Chief Scientist outlines plans to begin a THC Pharmaceutical Development Program by executing comprehensive research to develop specific, custom formulations and novel delivery mechanisms for cannabinoid and THC based drugs for a variety of ailments including chronic pain, inflammation, migraines, seizures related to epilepsy, nausea associated with cancer treatment, and numerous others.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.